Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.

van der Laan AM, Hirsch A, Robbers LF, Nijveldt R, Lommerse I, Delewi R, van der Vleuten PA, Biemond BJ, Zwaginga JJ, van der Giessen WJ, Zijlstra F, van Rossum AC, Voermans C, van der Schoot CE, Piek JJ.

Am Heart J. 2012 Jan;163(1):57-65.e2. doi: 10.1016/j.ahj.2011.09.002. Epub 2011 Nov 23.

2.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
3.

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.

Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, Kitabata H, Okochi K, Arita Y, Ishibashi K, Komukai K, Kataiwa H, Nakamura N, Hirata K, Tanaka A, Akasaka T.

J Am Coll Cardiol. 2009 Jul 7;54(2):130-8. doi: 10.1016/j.jacc.2009.04.021.

4.

The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.

Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY.

J Thromb Haemost. 2012 Jul;10(7):1231-41. doi: 10.1111/j.1538-7836.2011.04603.x.

5.
6.

Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.

Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM.

J Thromb Thrombolysis. 2009 Feb;27(2):123-9. doi: 10.1007/s11239-008-0197-y. Epub 2008 Feb 2.

PMID:
18246410
7.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.

Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.

PMID:
20691832
8.

Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty.

Tarantini G, Razzolini R, Cacciavillani L, Bilato C, Sarais C, Corbetti F, Marra MP, Napodano M, Ramondo A, Iliceto S.

Am J Cardiol. 2006 Oct 15;98(8):1033-40. Epub 2006 Aug 28.

PMID:
17027566
9.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20.

PMID:
20381654
10.

Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction.

Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):44-50. doi: 10.2459/JCM.0b013e32831967b2.

PMID:
19145116
11.

Post-reperfusion enhancement of CD14(+)CD16(-) monocytes and microvascular obstruction in ST-segment elevation acute myocardial infarction.

Tsujioka H, Imanishi T, Ikejima H, Tanimoto T, Kuroi A, Kashiwagi M, Okochi K, Ishibashi K, Komukai K, Ino Y, Kitabata H, Akasaka T.

Circ J. 2010 Jun;74(6):1175-82. Epub 2010 Apr 27.

12.

Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.

Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, de Caralt TM, Heras M, Bosch X, Azqueta M, Pare C, Brugada J.

Am J Cardiol. 2009 Oct 1;104(7):878-82. doi: 10.1016/j.amjcard.2009.05.025.

PMID:
19766750
14.

Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.

Haeck JD, Kuijt WJ, Koch KT, Bilodeau L, Henriques JP, Rohling WJ, Baan J Jr, Vis MM, Nijveldt R, van Geloven N, Groenink M, Piek JJ, Tijssen JG, Krucoff MW, De Winter RJ.

Heart. 2010 Feb;96(3):190-5. doi: 10.1136/hrt.2009.180448. Epub 2009 Oct 26.

PMID:
19858136
15.

Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.

Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J, Agati L.

J Am Coll Cardiol. 2009 Dec 1;54(23):2145-53. doi: 10.1016/j.jacc.2009.08.024.

16.
17.

Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.

Hallén J, Sejersten M, Johanson P, Atar D, Clemmensen PM.

Am J Cardiol. 2010 May 1;105(9):1223-8. doi: 10.1016/j.amjcard.2009.12.034. Epub 2010 Mar 11.

PMID:
20403470
18.

Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.

Arslan U, Kocaoğlu I, Balci MM, Gülkan B, Falay MY, Temizhan A.

Coron Artery Dis. 2013 Aug;24(5):404-11. doi: 10.1097/MCA.0b013e328361a98c.

PMID:
23612365
19.

Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.

Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, Appelbaum E.

Am J Cardiol. 2010 Sep 1;106(5):635-40. doi: 10.1016/j.amjcard.2010.04.012.

PMID:
20723637
20.

Role of pre-infarction angina and inflammatory status in the extent of microvascular obstruction detected by MRI in myocardial infarction patients treated by PCI.

Jesel L, Morel O, Ohlmann P, Germain P, Faure A, Jahn C, Coulbois PM, Chauvin M, Bareiss P, Roul G.

Int J Cardiol. 2007 Oct 1;121(2):139-47. Epub 2007 Jan 16.

PMID:
17223210

Supplemental Content

Support Center